We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Neutralization of SARS-CoV-2 Variants by mRNA and Adenoviral Vector Vaccine-Elicited Antibodies.
- Authors
Tada, Takuya; Zhou, Hao; Samanovic, Marie I.; Dcosta, Belinda M.; Cornelius, Amber; Herati, Ramin S.; Mulligan, Mark J.; Landau, Nathaniel R.
- Abstract
The increasing prevalence of SARS-CoV-2 variants has raised concerns regarding possible decreases in vaccine effectiveness. Here, neutralizing antibody titers elicited by mRNA-based and adenoviral vector-based vaccines against variant pseudotyped viruses were measured. BNT162b2 and mRNA-1273-elicited antibodies showed modest neutralization resistance against Beta, Delta, Delta plus and Lambda variants whereas Ad26.COV2.S-elicited antibodies from a significant fraction of vaccinated individuals had less neutralizing titer (IC50 <50). The data underscore the importance of surveillance for breakthrough infections that result in severe COVID-19 and suggest a potential benefit by second immunization following Ad26.COV2.S to increase protection from current and future variants.
- Subjects
SARS-CoV-2; SARS-CoV-2 Delta variant; VACCINE effectiveness; IMMUNOGLOBULINS; BREAKTHROUGH infections
- Publication
Frontiers in Immunology, 2022, Vol 13, p1
- ISSN
1664-3224
- Publication type
Article
- DOI
10.3389/fimmu.2022.797589